HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) An erratum has been published Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by David, R. Articles by Franz, W.-M. Search for Related Content PubMed PubMed Citation Articles by David, R. Articles by Franz, W.-M.

Magnetic Cell Sorting Purification of Differentiated Embryonic Stem Cells Stably Expressing Truncated Human CD4 as Surface Marker

University Clinic, Med I, Munich, Germany

Key Words. ES cells • Magnetic cell sorting • CD4 • Cell transplantation

Correspondence: Wolfgang-Michael Franz, M.D., Ph.D, Klinikum Großhadern, Marchioninistraße 15, 81377 München, Germany. Telephone: 49-89-7095-6095; Fax: 49-89-7095-6094; e-mail: wolfgang.franz{at}med.uni-muenchen.de

Embryonic stem (ES) cells offer great potential in regenerative medicine and tissue engineering. Clinical applications are still hampered by the lack of protocols for gentle, high-yield isolation of specific cell types for transplantation expressing no immunogenic markers. We describe labeling of stably transfected ES cells expressing a human CD4 molecule lacking its intracellular domain (CD4) under control of the phosphoglycerate kinase promoter for magnetic cell sorting (MACS). To track the labeled ES cells, we fused CD4 to an intracellular enhanced green fluorescent protein domain (CD4EGFP). We showed functionality of the membrane-bound fluorescent fusion protein and its suitability for MACS leading to purities greater than 97%. Likewise, expression of CD4 yielded up to 98.5% positive cells independently of their differentiation state. Purities were not limited by the initial percentage of CD4⁺ cells, ranging from 0.6%–16%. The viability of MACS-selected cells was demonstrated by reaggregation and de novo formation of embryoid bodies developing all three germ layers. Thus, expression of CD4 in differentiated ES cells may enable rapid, high-yield purification of a desired cell type for tissue engineering and transplantation studies.